Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor. [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating the diagnostic efficacy and safety of Technetium-99m H7ND Injection for diagnosing peritoneal metastasis in gastrointest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Peritoneal Metastasis

Drugs mentioned

• Technetium-99m H7ND Injection

Snippet

Sponsor: Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. | Conditions: Solid Tumor, Peritoneal Metastasis | Phase 2 | Status: RECRUITING